AUB
VRTX icon

Atlantic Union Bankshares’s Vertex Pharmaceuticals VRTX Stock Holding History

Atlantic Union Bankshares’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.47M Buy
14,494
+261
+2% +$122K 0.12% 159
2025
Q4 		$6.45M Sell
14,233
-455
-3% -$196K 0.12% 154
2025
Q3 		$5.75M Buy
14,688
+5,741
+64% +$2.4M 0.11% 179
2025
Q2 		$3.98M Buy
8,947
+7,876
+735% +$3.63M 0.09% 195
2025
Q1 		$519K Sell
1,071
-232
-18% -$108K 0.03% 229
2024
Q4 		$525K Sell
1,303
-6,255
-83% -$2.9M 0.03% 235
2024
Q3 		$3.52M Buy
7,558
+329
+5% +$158K 0.2% 113
2024
Q2 		$3.39M Buy
7,229
+1,719
+31% +$746K 0.21% 106
2024
Q1 		$2.3M Buy
5,510
+385
+8% +$163K 0.19% 108
2023
Q4 		$2.09M Buy
5,125
+999
+24% +$369K 0.19% 115
2023
Q3 		$1.43M Buy
4,126
+802
+24% +$280K 0.15% 133
2023
Q2 		$1.17M Buy
3,324
+2,361
+245% +$796K 0.12% 154
2023
Q1 		$303K Buy
+963
New +$289K 0.03% 241

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Atlantic Union Bankshares's VRTX Position: Q1 2026 in Review

Atlantic Union Bankshares increased its Vertex Pharmaceuticals (VRTX) stake by 1.8% in Q1 2026, buying an estimated $122K and bringing the position to 14,494 shares worth $6.47M. The position accounts for 0.12% of the portfolio, ranked #159.

Atlantic Union Bankshares first reported a position in VRTX in Q1 2023 and has held it in 13 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Atlantic Union Bankshares held 14,494 shares of Vertex Pharmaceuticals worth $6.47M as of Q1 2026.
  • Atlantic Union Bankshares bought 261 Vertex Pharmaceuticals shares in Q1 2026, an estimated $122K.
  • Vertex Pharmaceuticals made up 0.12% of Atlantic Union Bankshares's portfolio in Q1 2026, its #159 holding.
  • Atlantic Union Bankshares first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.